Navigation Links
A prescription cream for unwanted facial hair,,

VaniqaT is a prescription drug which was approved by the FDA in the United States on July 31, 2000 for treating excessive facial hair in women, which is often part of hirsutism.

It may be a welcome alternative for women for whom this problem is considered serious enough to warrant tweezing, waxing, or shaving at least once a week for hair removal. Vaniqa is actually not a brand new drug, but rather a new topical-use version of the older drug eflornithine (brand name Ornidyl).

Vaniqa, like Viagra, is considered to be a "lifestyle drug", a drug which generally improves our quality of life, but is not considered to be essential for good health. Vaniqa is the first prescription drug approved in the United States to treat this condition. It was effective, compared to placebo, in approximately 25% of women who used it during the pre-release clinical trials. Although Vaniqa currently appears have few side effects, when used as directed, post-release experience often modifies the safety profile for new drugs.
'"/>




Page: 1

Related medicine news :

1. Patients Pressure Would Result In Overprescription
2. TV drug commercials prompt prescriptions
3. Status of some prescription drugs
4. Abuse of prescription drugs among youths on the rise
5. Bush’s new prescription drug plan, a complex puzzle for the citizen
6. Many Nonprescription Cough Medicines Proves Ineffective
7. A urine test for ease in prescription of drugs and therapies
8. Doctors to give complete information on prescriptions to patients
9. U S Government Allows Non-prescription Diet Pill
10. Lifestyle changes not prescription drugs to fight diabetes, say scientists
11. Sun burns treated with creams
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... W.S. Badger Co. Inc ., the maker of ... recognized as one of the best small businesses for new dads by Fatherly, the ... small businesses providing progressive benefits to new parents on the organization’s 2016 Best ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... New Zealand , May 24, 2016 ... and informatics solutions for the healthcare sector, has been named ... New Zealand Hi-Tech Awards 2016. Dr Bruce ... fantastic acknowledgement for our team.  It,s really good to be ... burden healthcare internationally. Our products are used in 35 countries ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology: